Connect with us

Hi, what are you looking for?

Editor's Pick

Four Republicans buck Mike Johnson to join Hakeem Jeffries’ Obamacare push

Four moderate House Republicans are rebelling against Speaker Mike Johnson, R-La., to join his Democratic counterpart in forcing a vote on enhanced Obamacare subsidies set to expire at the end of this year.

Reps. Brian Fitzpatrick, R-Pa., Ryan Mackenzie, R-Pa., Rob Bresnahan, R-Pa., and Mike Lawler, R-N.Y., all joined a discharge petition by House Minority Leader Hakeem Jeffries, D-N.Y., on his push for a three-year extension of the subsidies.

A discharge petition is a mechanism for overriding the will of House leaders to get a chamber-wide vote on specific legislation, provided it has support from a majority of lawmakers.

In this case, the four House Republicans’ signatures put Jeffries’ petition at 218 — clinching the critical majority threshold.

‘I’ve always supported bipartisan solutions that would bring about healthcare affordability in this country,’ Mackenzie told Fox News Digital on Wednesday of his decision. ‘Leader Jeffries and the Democrats have refused to sign onto either of those bipartisan solutions. And so at this point, our leadership is not calling up a bill to extend the [Obamacare] tax credits.’

He called for a vote on the Democrat-led solution as well as two bipartisan bills offering one and two-year extensions, respectively, with reforms.

It comes despite Johnson warning Republicans earlier on Wednesday not to support Jeffries’ petition, arguing it was not the best way to legislate.

Johnson told CNBC’s ‘Squawk Box’ that it was effectively ‘doing an end-run around the majority party, the speaker or the regular process is not the best way to make law.’

The House is expected to vote on a bill that Republicans say is aimed at lowering healthcare costs for all Americans, without extending the subsidies — which they argue are part of a deeply flawed public healthcare system.

Moderate Republicans offered several amendments to the legislation aimed at extending the Obamacare subsidies during a House Rules Committee meeting to advance the bill on Tuesday, but all were rejected by their fellow GOP lawmakers on the panel.

‘While I have been working for a bipartisan compromise with reforms, the failure of leadership to allow a vote on the floor left me with no choice but to sign the Democrats’ discharge petition,’ Lawler said in a statement on X.

‘The speaker should immediately bring it to the floor for an up-or-down vote and let the House do the work of the American people.’

Because of the timing constraints of a discharge petition, the earliest the House could consider the Jeffries bill would be early next year.

This post appeared first on FOX NEWS

    Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!


    By signing up, you're cool with getting emails from us. Don’t worry—your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    You May Also Like

    Investing

    Fisker (NYSE: FSR) stock price has been one of the best-performing electric vehicle (EV) stocks this week even as Tesla slumped. The shares jumped...

    Investing

    Newmont (NYSE: NEM) reported mixed financial results even as the price of gold approached its all-time high. In all, the company’s earnings per share...

    Investing

    The Fox Corporation (NASDAQ: FOX) stock price has been under pressure as investors come to terms with the abrupt firing of Tucker Carlson. The...

    Investing

    NatWest (LON: NWG) share price rose sharply, helped by the strong results from Barclays. The stock jumped to a high of 274.8p, which was...




    Disclaimer: Oldamericanbroker.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the-company.


    Copyright © 2026 oldamericanbroker.com | All Rights Reserved